Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brettell

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Advanced Nursing|January 1, 1988
Patterns of evaluations of accents amongst health visitor studentsK M Brettell
American Journal of Respiratory Cell and Molecular Biology|March 1, 1994
Basic fibroblast growth factor decreases elastin production by neonatal rat lung fibroblastsL M Brettell, S E McGowan
American Journal of Hematology|January 1, 1979
Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukaemia (CLL) and lymphocytic lymphomaI A Cooper, J C Ding, P B Adams, et al.
Journal of Clinical Apheresis|June 4, 1999
Comparison of COBE Spectra software version 4.7 PBSC and version 6.0 auto PBSC programR Wilke, M Brettell, H M Prince, et al.
Bone Marrow Transplantation|August 26, 1998
Peripheral blood CD34+ cell count reliably predicts autograft yieldP Chapple, H M Prince, M Quinn, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Bone Marrow Transplantation|December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, D Rischin, G C Toner, et al.
Bone Marrow Transplantation|October 6, 2000
Docetaxel effectively mobilizes peripheral blood CD34+ cellsH M Prince, G C Toner, J F Seymour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, M J Millward, D Rischin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Advanced Nursing|January 1, 1988
Patterns of evaluations of accents amongst health visitor studentsK M Brettell
American Journal of Respiratory Cell and Molecular Biology|March 1, 1994
Basic fibroblast growth factor decreases elastin production by neonatal rat lung fibroblastsL M Brettell, S E McGowan
American Journal of Hematology|January 1, 1979
Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukaemia (CLL) and lymphocytic lymphomaI A Cooper, J C Ding, P B Adams, et al.
Journal of Clinical Apheresis|June 4, 1999
Comparison of COBE Spectra software version 4.7 PBSC and version 6.0 auto PBSC programR Wilke, M Brettell, H M Prince, et al.
Bone Marrow Transplantation|August 26, 1998
Peripheral blood CD34+ cell count reliably predicts autograft yieldP Chapple, H M Prince, M Quinn, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Bone Marrow Transplantation|December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, D Rischin, G C Toner, et al.
Bone Marrow Transplantation|October 6, 2000
Docetaxel effectively mobilizes peripheral blood CD34+ cellsH M Prince, G C Toner, J F Seymour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, M J Millward, D Rischin, et al.
Pageof 1